Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas

Human Molecular Genetics

Volumn 14, Issue 5, 2005, Pages 603-614

  Rebouissou, Sandra ^a   Vasiliu, Viorel ^b   Thomas, Cristel ^a   Bellanné Chantelot, Christine ^c   Bui, Hung ^a   Chrétien, Yves ^b   Timsit, José ^d   Rosty, Christophe ^e   Laurent Puig, Pierre ^f   Chauveau, Dominique ^b   Zucman Rossi, Jessica ^a  

^a FONDATION JEAN DAUSSET CEPH   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d Institut Curie ^*  (France)

^e INSTITUT CURIE   (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROCYSTIN; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; NUCLEAR FACTOR I; TAMM HORSFALL GLYCOPROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CANCER TISSUE; CARCINOGENESIS; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INACTIVATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC SCREENING; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; KIDNEY TUMOR; MALE; OVARY TUMOR; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, RENAL CELL; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 20044396898     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi057     Document Type: Article

References (41)

1. Cereghini, S. (1996) Liver-enriched transcription factors and hepatocyte differentiation. FASEB J., 10, 267-282.
2. Courtois, G., Morgan, J.G., Campbell, L.A., Fourel, G. and Crabtree, G.R. (1987) Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. Science, 238 688-692.
3. Frain, M., Swart, G., Monaci, P., Nicosia, A., Stampfli, S., Frank, R. and Cortese, R. (1989) The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell, 59, 145-157.
4. Cereghini, S., Raymondjean, M., Carranca, A.G., Herbomel, P. and Yaniv, M. (1987) Factors involved in control of tissue-specific expression of albumin gene. Cell, 50, 627-638.
5. Rey-Campos, J., Chouard, T., Yaniv, M. and Cereghini, S. (1991) vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J., 10, 1445-1457.
6. Sladek, F.M., Zhong, W.M., Lai, E. and Darnell, J.E., Jr. (1990) Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev., 4, 2353-2365.
7. Li, J., Ning, G. and Duncan, S.A. (2000) Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev., 14, 464-474.
8. Fajans, S.S., Bell, G.I. and Polonsky, K.S. (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med., 345, 971-980.
9. Yamagata, K., Oda, N., Kaisaki, P.J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R.D., Lathrop, G.M., Boriraj, V.V. et al. (1996) Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature, 384, 455-458.
10. Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B.N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O. et al. (1997) Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat. Genet., 17, 384-385.
11. Yamagata, K., Furuta, H., Oda, N., Kaisaki, P.J., Menzel, S., Cox, N.J., Fajans, S.S., Signorini, S., Stoffel, M. and Bell, G.I. (1996) Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature, 384, 458-460.
12. Woolf, A.S. (2000) Diabetes, genes, and kidney development. Kidney Int., 57, 1202-1203.
13. Bellanne-Chantelot, C., Chauveau, D., Gautier, J.F., Dubois-Laforgue, D., Clauin, S., Beaufils, S., Wilhelm, J.M., Boitard, C., Noel, L.H., Velho, G. et al. (2004) Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann. Intern. Med., 140, 510-517.
14. Bluteau, O., Jeannot, E., Bioulac-Sage, P., Marques, J.M., Blanc, J.F., Bui, H., Beaudoin, J.C., Franco, D., Balabaud, C., Laurent-Puig, P. et al. (2002) Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat. Genet., 32, 312-315.
15. Bacq, Y., Jacquemin, E., Balabaud, C., Jeannot, E., Scotto, B., Branchereau, S., Laurent, C., Bourlier, P., Pariente, D., de Muret, A. et al. (2003) Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology, 125, 1470-1475.
16. Reznik, Y., Dao, T., Coutant, R., Chiche, L., Jeannot, E., Clauin, S., Rousselot, P., Fabre, M., Oberti, F., Fatome, A. et al. (2004) Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J. Clin. Endocrinol. Metab. 89, 1476-1480.
17. Laurent-Puig, P., Plomteux, O., Bluteau, O., Zinzindohoue, F., Jeannot, E., Dahan, K., Kartheuser, A., Chapusot, C., Cugnenc, P.H. and Zucman-Rossi, J. (2003) Frequent mutations of hepatocyte nuclear factor 1 in colorectal cancer with microsatellite instability. Gastroenterology, 124, 1311-1314.
18. Gresh, L., Fischer, E., Reimann, A., Tanguy, M., Garbay, S., Shao, X., Hiesberger, T., Fiette, L., Igarashi, P., Yaniv, M. et al. (2004) A transcriptional network in polycystic kidney disease. EMBO J., 23, 1657-1668.
19. Hiesberger, T., Bai, Y., Shao, X., McNally, B.T., Sinclair, A.M., Tian, X., Somlo, S. and Igarashi, P. (2004) Mutation of hepatocyte nuclear factor-1beta inhibits Pkhd1 gene expression and produces renal cysts in mice. J. Clin. Invest., 113, 814-825.
20. Ellard, S. (2000) Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. Hum. Mutat. 16, 377-385.
21. Kovacs, G., Akhtar, M., Beckwith, B.J., Bugert, P., Cooper, C.S., Delahunt, B., Eble, J.N., Fleming, S., Ljungberg, B., Medeiros, L.J. et al. (1997) The Heidelberg classification of renal cell tumours. J. Pathol., 183, 131-133.
22. Storkel, S., Eble, J.N., Adlakha, K., Amin, M., Blute, M.L., Bostwick, D.G., Darson, M., Delahunt, B. and Iczkowski, K. (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer, 80, 987-989.
23. Thoenes, W., Storkel, S., Rumpelt, H.J., Moll, R., Baum, H.P. and Werner, S. (1988) Chromophobe cell renal carcinoma and its variants - a report on 32 cases. J. Pathol., 155, 277-287.
24. Crotty, T.B., Farrow, G.M. and Lieber, M.M. (1995) Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J. Urol., 154, 964-967.
25. Storkel, S., Steart, P.V., Drenckhahn, D. and Thoenes, W. (1989) The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol., 56, 237-245.
26. Bugert, P., Gaul, C., Weber, K., Herbers, J., Akhtar, M., Ljungberg, B. and Kovacs, G. (1997) Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab. Invest., 76, 203-208.
27. Contractor, H., Zariwala, M., Bugert, P., Zeisler, J. and Kovacs, G. (1997) Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour. J. Pathol., 181, 136-139.
28. Pavlovich, C.P., Walther, M.M., Eyler, R.A., Hewitt, S.M., Zbar, B., Linehan, W.M. and Merino, M.J. (2002) Renal tumors in the Birt-Hogg-Dube syndrome. Am. J. Surg. Pathol., 26, 1542-1552.
29. Ward, C.J., Hogan, M.C., Rossetti, S., Walker, D., Sneddon, T., Wang, X., Kubly, V., Cunningham, J.M., Bacallao, R., Ishibashi, M. et al. (2002) The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet., 30, 259-269.
30. Xiong, H., Chen, Y., Yi, Y., Tsuchiya, K., Moeckel, G., Cheung, J., Liang, D., Tham, K., Xu, X., Chen, X.Z. et al. (2002) A novel gene encoding a TIG multiple domain protein is a positional candidate for autosomal recessive polycystic kidney disease. Genomics 80, 96-104.
31. Onuchic, L.F., Furu, L., Nagasawa, Y., Hou, X., Eggermann, T., Ren, Z., Bergmann, C., Senderek, J., Esquivel, E., Zeltner, R. et al. (2002) PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am. J. Hum. Genet., 70, 1305-1317.
32. Lemm, I., Lingott, A., Pogge v Strandmann, E., Zoidl, C., Bulman, M.P., Hattersley, A.T., Schulz, W.A., Ebert, T. and Ryffel, G.U. (1999) Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene. Mol. Carcinog. 24, 305-314.
33. Argani, P., Lal, P., Hutchinson, B., Lui, M.Y., Reuter, V.E. and Ladanyi, M. (2003) Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol., 27, 750-761.
34. Clairmont, A., Ebert, T., Weber, H., Zoidl, C., Eickelmann, P., Schulz, W.A., Sies, H. and Ryffel, G.U. (1994) Lowered amounts of the tissue-specific transcription factor LFB1 (HNF1) correlate with decreased levels of glutathione S-transferase alpha messenger RNA in human renal cell carcinoma. Cancer Res., 54, 1319-1323.
35. Sel, S., Ebert, T., Ryffel, G.U. and Drewes, T. (1996) Human renal cell carcinogenesis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4 alpha and HNF1 alpha. Cancer Lett., 101, 205-210.
36. Rebouissou, S., Rosty, C., Lecuru, F., Boisselier, S., Bui, H., le Frere-Belda, A., Sastre, X., Laurent-Puig, P. and Zucman-Rossi, J. (2004) Mutation of TCF1 encoding hepatocyte nuclear factor 1α in gynecological cancer. Oncogene, 23, 7588-7592.
37. Zhang, M.Z., Mai, W., Li, C., Cho, S.Y., Hao, C., Moeckel, G., Zhao, R., Kim, I., Wang, J., Xiong, H. et al. (2004) PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. Proc. Natl Acad. Sci. USA, 101, 2311-2316.
38. Eble, IN., Sauter, G., Epstein, J.I. and Sesterhenn, I.A. (2004) Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. IARC Press, Lyon.
39. Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
40. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
41. Ramakers, C., Ruijter, J.M., Deprez, R.H. and Moorman, A.F. (2003) Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett., 339, 62-66.